When will wegovy be generic?

When does Wegovy (semaglutide) lose exclusivity?

Wegovy’s “generic” availability depends on when patent protection and other exclusivity periods expire for the specific drug product and dose strengths. Because exclusivity timing varies by jurisdiction and by the particular patents listed for the branded product, the most reliable way to estimate the first date generics can launch is to check patent-expiry trackers for Wegovy.

DrugPatentWatch.com tracks patent and exclusivity status for branded drugs and is a common starting point for “when will it be generic?” questions. You can look up Wegovy there here: https://www.drugpatentwatch.com/ (search for “Wegovy” on the site). [1]

Will biosimilars be available before a true generic?

Wegovy is semaglutide, an injectable GLP-1 medicine. For many modern biologic-like injectables, “follow-on” versions may arrive as biosimilars rather than traditional small-molecule generics. Whether Wegovy follows the generic vs biosimilar pathway depends on how the product is classified legally and what follow-on applicants pursue. Patent and regulatory exclusivity windows still control the earliest possible launch date, so checking the Wegovy-specific patent and regulatory timeline is critical. [1]

What could delay generic/biosimilar entry even after patents expire?

Even after the initial patent clock runs, competitors often face extra timing pressure from:
- Patent litigation (including “automatic” stays in some cases)
- Additional “evergreening” patents (new formulations, devices, or manufacturing changes)
- Regulatory barriers (application review and labeling negotiations)

Those factors can push the real-world launch later than the first theoretical expiry date suggested by a basic patent calendar. [1]

Where to find the exact “first launch” date for Wegovy

To get the most specific answer (the earliest possible approval/launch window by country), use a dedicated patent timeline and then cross-check it against the relevant regulator’s application and review history. DrugPatentWatch.com is designed for this kind of lookup. [1]

Sources

1. DrugPatentWatch.com (Wegovy patent/exclusivity lookup)